AISight Dx
Overview
AISight Dx is PathAI’s FDA-cleared, cloud-native digital pathology image management system, meticulously designed to modernize anatomic pathology workflows and enhance diagnostic precision. It serves as a central hub for case and image management, integrating advanced AI algorithms to support laboratory operations, clinical workflows, and primary diagnosis in the US. The platform enables pathologists to intuitively view, interpret, share, and manage whole slide images, offering end-to-end workflow support. AISight Dx is built for interoperability, connecting with most major laboratory information systems (LIS) and various slide scanners, including Leica Aperio® GT 450 DX, Hamamatsu NanoZoomer® S360MD, Roche VENTANA® DP200 and DP600. It is also CE-IVDR certified for primary diagnosis in the EEA, UK, and Switzerland.
The system is AI-native, designed to seamlessly integrate PathAI’s own AI-powered tools and a growing list of over 40 third-party algorithms for use in research, workflow optimization, assisted scoring, and biomarker quantification. Key functionalities include intelligent case routing, automated assignment, real-time collaboration, and structured reporting, all aimed at optimizing operational efficiency and accelerating turnaround times. PathAI leverages extensive datasets, including over 20 million annotations from a network of over 550 pathologists, to rigorously train and validate its AI models, ensuring high diagnostic accuracy and consistency.
Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Key Features
- Cloud-native image management system
- AI-powered workflow optimization (e.g., case prioritization, automated assignment)
- High-performance whole slide image viewing and interpretation
- Seamless integration of PathAI and third-party AI algorithms
- Real-time multi-institutional collaboration (AISight Live)
- Intelligent case routing and management
- Structured reporting and voice-enabled reporting support
- Interoperability with major LIS and slide scanners
- Biomarker quantification and analysis
- Flexible slide tray organization and ingestion flexibility
Use Cases
- Primary diagnosis in clinical settings
- Translational research and biomarker discovery
- Drug development and clinical trials support
- Digital pathology workflow management
- Education and training
- Quality control and assurance
Details
| Category | Pathology AI |
| Pricing |
Contact for quote
|
| Deployment | Cloud-native |
| Compliance | |
| BAA Available | Unknown AI-estimated |
| HIPAA Compliant | Unknown AI-estimated |
| FDA Status |
1 AI-estimated PathAI's AISight Dx received 510(k) clearance from the U.S. FDA for use in primary diagnosis in clinical settings. It is cleared for use with specific slide scanners including Leica Aperio® GT 450 DX, Hamamatsu NanoZoomer® S360MD, Roche VENTANA® DP200 and DP600. |
| Integrations | |
| EHR | Not specified |
| Specialties | Pathology |
What the Web Says
AISight Dx by PathAI is a digital pathology image management system designed to streamline pathology workflows, enhance diagnostic accuracy, and facilitate collaboration among pathologists. It has received FDA clearance for primary diagnosis in the US and CE-IVD mark in Europe, indicating its readiness for clinical use. The platform aims to move beyond traditional glass slide methods by enabling digital case submission, review, and reporting, which can reduce turnaround times and shipping costs.
Overall: PositiveStrengths
- Improved efficiency and accelerated turnaround times in pathology workflows.
- Enhanced diagnostic accuracy and consistency through AI-powered tools.
- Seamless collaboration among pathologists, including real-time and asynchronous slide review.
- Reduced manual effort and operational burden for consulting and referring institutions.
- Scalability to handle large volumes of data and adapt to growing laboratory needs.
- Integration with laboratory information systems (LIS) for smooth data transfer and reduced manual tasks.
Limitations
- Some Reddit users express concern about AI potentially replacing pathologists or reducing demand for their services.
- The initial implementation and configuration process can be complex and require significant effort.
- Limited features or metrics issues in some aspects, potentially requiring extra interpretation or customization.
- Concerns about integration issues and a lack of cohesiveness with existing tools in some cases.
- Not intended for use with frozen sections, cytology, or non-FFPE hematopathology specimens.
- Some features are currently in development and available only to select partners.
Based on reviews from: PathAI.com, HIT Consultant, Medical Device Network, G2, Reddit, Capterra, Digital Innovation and Transformation
Last updated: 2026-07-23
Ratings & Reviews
No reviews yet. Be the first to review this tool!
Rate AISight Dx
Press & Coverage
Videos
Product demos, reviews, and walkthroughs for AISight Dx.
AISight Image Management System
PathAI
Frequently Asked Questions
Investors who backed AISight Dx
Funded through the company that built this tool.
